Connect with us

Technology

Apple Inc (NASDAQ:AAPL) And BioTelemetry Inc (NASDAQ:BEAT) Finalizes A Deal

Published

on

BioTelemetry Inc (NASDAQ:BEAT) the major mobile and wireless medical know-how firm focused on offering health information to lower cost of care and enhance quality of life, reported an association with Apple Inc (NASDAQ:AAPL) to offer cardiac monitoring services together with the Apple Heart Study. This study is projected to identify undiagnosed irregular heart rhythms, like atrial fibrillation, utilizing the Apple Watch and the “Apple Heart Study” App.

The details

Joseph H. Capper, the CEO and President of BioTelemetry, expressed that they are extremely thrilled to be participating in this possibly advanced study. Too often, the initial sign of a cardiac arrhythmia is the incidence of a life-threatening event. The initiative of Apple will potentially benefit many individuals who are uninformed that they may be at peril for grave health issues. BioTelemetry offers cardiac monitoring, centralized medical imaging, original equipment manufacturing and mobile blood glucose monitoring that serve both the Clinical Research and Healthcare industries.

In unrelated news, Apple’s CEO Tim Cook expressed that developers utilizing its platform in China count at 1.8 million and have recorded a total 112 billion yuan, exhibiting around a quarter of total international App Store revenue. Cook revealed the data during a speech at leading public cyber policy forum, organized by the CAC, which looks after internet regulation including censorship. Earlier this year, the company reported that developers had recorded total revenue of around $70 billion through the store.

Apple is fronting criticism from rights groups and local users for bowing to pressure from cyber regulators in Beijing after it said to remove several apps from its Chinese store, including virtual private network and messaging apps services, which help customers overthrow China’s Great Firewall. The company counts China as one of the key region by sales, however it has eroded market share in last few years as high-end devices from local peers continue to gain traction. Apple is expecting to regain its lost market share following the launch of its iPhone X and iPhone 8 devices which shipped in November.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement